Real-World cancer drug study completes with 61 patients
NCT ID NCT05381753
Summary
This study observed how the drug avapritinib worked for Chinese patients with a specific type of stomach and intestinal cancer called GIST in real-world hospital settings. It involved 61 patients with different genetic types of the tumor to see how safe the drug was and how well it controlled their disease. The goal was to gather information on side effects and treatment effectiveness outside of a controlled clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL STROMAL TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100000, China
Conditions
Explore the condition pages connected to this study.